Depression induced by chronic corticosterone treatment generates neuroinflammation.
Enriched environment reduces depression-linked neuroinflammation.
Enriched environment promotes anti-inflammatory microglia and brain macrophage phenotype.
Adiponectin exerts anti-inflammatory properties by acting on microglia and brain macrophages.
Adiponectin intracerebroventricular injection reduces depressive-like behavior.